The average one-year price target for Ocugen (NasdaqCM:OCGN) has been revised to $10.20 / share. This is an increase of 11.11% from the prior estimate of $9.18 dated February 21, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $7.07 to a high of $15.75 / share. The average price target represents an increase of 420.41% from the latest reported closing price of $1.96 / share.
What is the Fund Sentiment?
There are 119 funds or institutions reporting positions in Ocugen. This is an decrease of 32 owner(s) or 21.19% in the last quarter. Average portfolio weight of all funds dedicated to OCGN is 0.01%, an increase of 53.81%. Total shares owned by institutions increased in the last three months by 26.33% to 60,965K shares. 
The put/call ratio of OCGN is 0.13, indicating a bullish outlook.
What are Other Shareholders Doing?
Millennium Management holds 5,396K shares representing 1.60% ownership of the company. In its prior filing, the firm reported owning 4,162K shares , representing an increase of 22.87%. The firm increased its portfolio allocation in OCGN by 5.80% over the last quarter.
UBS Group holds 4,849K shares representing 1.44% ownership of the company. In its prior filing, the firm reported owning 1,025K shares , representing an increase of 78.87%. The firm increased its portfolio allocation in OCGN by 305.66% over the last quarter.
Geode Capital Management holds 3,819K shares representing 1.13% ownership of the company. In its prior filing, the firm reported owning 3,677K shares , representing an increase of 3.72%. The firm decreased its portfolio allocation in OCGN by 16.77% over the last quarter.
Marshall Wace, Llp holds 2,531K shares representing 0.75% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Goldman Sachs Group holds 2,302K shares representing 0.68% ownership of the company. In its prior filing, the firm reported owning 98K shares , representing an increase of 95.76%. The firm increased its portfolio allocation in OCGN by 1,866.73% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
